Refining what clinicians see and treat in outer retinal disease with Christine Curcio, PhD

News
Video

Christine A. Curcio, PhD, shares an update on histology and its critical role in advancing <3 μm optical coherence tomography interpretation

Christine A. Curcio, PhD, spoke to the Eye Care Network about her presentation at the 2025 International SPECTRALIS Symposium – And Beyond (ISS). At this year's ISS meeting, held on 13 and 14 June in Heidelberg, Germany, Prof Curcio spoke on histology and optical coherence tomography (OCT) interpretation. She recounted details of that lecture in the above video.

Curcio is the emerita professor of ophthalmology and visual sciences at the University of Alabama at Birmingham Heersink School of Medicine, in Birmingham, Alabama. Prof Curcio and her team use volume electron microscopy to correlate high-resolution tissue data with OCT B-scans. New techniques in histology are refining the way clinicians use software tools, and the OCT nomenclature used to describe findings, Prof Curcio said.

“We built on the success of the 2014 international OCT consensus by Staurenghi et al,” Curcio said. She refers here to a landmark framework, developed by clinicians in Italy, the United Kingdom, California and New York, published in Ophthalmology.1 The consensus introduced terms, such as ellipsoid zone and interdigitation zone, which are a key aspect of retinal research today. A detailed and accurate imaging framework is crucial to understanding retinal disease, she noted. “Attention to precision is really essential,” she said.

Reference

  1. Staurenghi G, Sadda S, Chakravarthy U, Spaide RF; International Nomenclature for Optical Coherence Tomography (IN•OCT) Panel. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus. Ophthalmology. 2014;121(8):1572-1578. doi:10.1016/j.ophtha.2014.02.023

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.